1
|
Metabolic Stability and Metabolite Characterization of Capilliposide B and Capilliposide C by LC⁻QTRAP⁻MS/MS. Pharmaceutics 2018; 10:pharmaceutics10040178. [PMID: 30297638 PMCID: PMC6321230 DOI: 10.3390/pharmaceutics10040178] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2018] [Revised: 09/27/2018] [Accepted: 10/04/2018] [Indexed: 01/18/2023] Open
Abstract
Capilliposide B (LC-B) and Capilliposide C (LC-C), two new triterpenoid saponins extracted from Lysimachia capillipes Hemsl, exhibit potential anticancer activity both in vitro and in vivo. However, their metabolic process remains unclear. In this study, the metabolic stability of LC-B, LC-C, and Capilliposide A (LC-A, a bioactive metabolite of LC-B and LC-C) was investigated in human, rat, and mouse liver microsomes, respectively. Thereafter, their metabolites were identified and characterized after oral administration in mice. As a result, species difference was found in the metabolic stability of LC-B and LC-C. All three compounds of interest were stable in human and rat liver microsomes, but LC-B and LC-C significantly degraded in mouse liver microsomes. The metabolic instability of LC-B and LC-C was mainly caused by esterolysis. Moreover, 19 metabolites were identified and characterized in mouse biological matrices. LC-B and LC-C mainly underwent deglycosylation and esterolysis, accompanied by dehydration, dehydrogenation, and hydroxylation as minor metabolic reactions. Finally, the metabolic pathway of LC-B and LC-C in mice was proposed. Our results updated the preclinical metabolism and disposition process of LC-B and LC-C, which provided additional information for better understanding efficacy and safety.
Collapse
|
2
|
Cheng Z, Zhou X, Hu B, Li W, Chen G, Zhang Y, Tian J, Zhang L, Li M, Jiang H. Tissue distribution of capilliposide B, capilliposide C and their bioactive metabolite in mice using liquid -tandem mass spectrometry. Biomed Chromatogr 2016; 31. [PMID: 27859436 DOI: 10.1002/bmc.3895] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2016] [Revised: 10/25/2016] [Accepted: 11/10/2016] [Indexed: 01/23/2023]
Abstract
Lysimachia capillipes Hemsl (Primulaceae), a folk medicinal plant in China, showed significant anti-tumor activities in vivo and in vitro. Capilliposide B (LC-B) and capilliposide C (LC-C) are the main bioactive components in this plant. To explore their tissue distribution, a reliable bioanalytical method for the quantification of LC-B, LC-C and their bioactive metabolite, capilliposide A (LC-A), in mouse tissues was developed and validated. In this study, the tissue distribution profiles of the three compounds were examined after intravenous administration of pure LC-B and oral administration of total saponins of L. capillipes Hemsl extract (LCE) for 10 days. Method validation was conducted over the curve range 10.0-5000 ng/mL for all three analytes in various tissue homogenates. The relative standard deviation of intra-day and inter-day precision of the QC samples was <14.7%, and the accuracy ranged from 85.9 to 114.0%. The results indicated that LC-B was rapidly and widely distributed throughout the whole body except for muscle following intravenous administration of LC-B. In addition, LC-A was only in liver, intestine, lung and stomach. After oral administration of LCE, LC-B and LC-C were distributed into various tissues. The highest levels were observed in stomach and intestine.
Collapse
Affiliation(s)
- Zhongzhe Cheng
- School of Pharmacy, Weifang Medical University, Weifang, Shandong, China
| | - Xing Zhou
- Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Bingying Hu
- Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Wenyi Li
- Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Guiying Chen
- Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Yang Zhang
- Department of Pharmacy, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Jingkui Tian
- Department of Biomedical Engineering, Zhejiang University, Hangzhou, Zhejiang, China
| | - Lin Zhang
- Department of Biomedical Engineering, Zhejiang University, Hangzhou, Zhejiang, China
| | - Ming Li
- Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Hongliang Jiang
- Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan, Hubei, China
| |
Collapse
|
3
|
Cheng Z, Zhou X, Li W, Hu B, Zhang Y, Xu Y, Zhang L, Jiang H. Optimization of solid-phase extraction and liquid chromatography-tandem mass spectrometry for simultaneous determination of capilliposide B and its active metabolite in rat urine and feces: Overcoming nonspecific binding. J Pharm Biomed Anal 2016; 131:6-12. [DOI: 10.1016/j.jpba.2016.08.003] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2016] [Revised: 08/01/2016] [Accepted: 08/03/2016] [Indexed: 10/21/2022]
|
4
|
Yang G, Zhang F, Deng L, Chen C, Cheng Z, Huang J, Liu J, Jiang H. Development and validation of an LC-MS/MS method for simultaneous quantification of levodopa and MD01 in rat plasma and its application to a pharmacokinetic study ofmucuna pruriensextract. Biomed Chromatogr 2016; 30:1506-14. [DOI: 10.1002/bmc.3714] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2015] [Revised: 02/16/2016] [Accepted: 02/22/2016] [Indexed: 11/08/2022]
Affiliation(s)
- Guangjie Yang
- Tongji School of Pharmacy; Huazhong University of Scinence and Technology; 13 Hangkong Road Wuhan 430030 Hubei China
| | - Fangrong Zhang
- Tongji School of Pharmacy; Huazhong University of Scinence and Technology; 13 Hangkong Road Wuhan 430030 Hubei China
| | - Linfang Deng
- College of Pharmaceutical Sciences; Soochow University; Suzhou 215123 Jiangsu China
| | - Chang Chen
- Tongji School of Pharmacy; Huazhong University of Scinence and Technology; 13 Hangkong Road Wuhan 430030 Hubei China
| | - Zhongzhe Cheng
- Tongji School of Pharmacy; Huazhong University of Scinence and Technology; 13 Hangkong Road Wuhan 430030 Hubei China
- School of Pharmacy; Weifang Medical University; Weifang 261053 Shandong China
| | - Jiangeng Huang
- Tongji School of Pharmacy; Huazhong University of Scinence and Technology; 13 Hangkong Road Wuhan 430030 Hubei China
| | - Jiangyun Liu
- College of Pharmaceutical Sciences; Soochow University; Suzhou 215123 Jiangsu China
| | - Hongliang Jiang
- Tongji School of Pharmacy; Huazhong University of Scinence and Technology; 13 Hangkong Road Wuhan 430030 Hubei China
| |
Collapse
|